IP Library › Granted Patent US 8,927,015
Granted Patent B2
US 8,927,015 · App. 12/297,147 · Granted Jan 6, 2015

Formulations for delivering insulin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,927,015
App. No.
12/297,147
Granted
Jan 6, 2015
Kind
B2
Abstract

Oral insulin formulations and processes for preparing oral insulin formulations are provided.

Claims (1)

1. A tablet consisting of 240 mg sodium 4-[(2-hydroxy-4-chlorobenzoyl)amino]butanoate, 12 mg gelatin, 5.45 mg insulin, 113.8 mg dibasic calcium phosphate and 3.75 mg magnesium stearate.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2021
From: EMISPHERE TECHNOLOGIES, INC.
To: NOVO NORDISK NORTH AMERICA OPERATIONS A/S
Reel/Frame 056750/0169 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2008
From: LEVCHIK, HALINA; OYEWUMI, MOSES O.; MAJURU, SHINGAI; BAY, WILLIAM ELLIOTT; LIAO, JUN; LIU, PUCHUN; DINH, STEVEN; DHOOT, NIKHIL
To: EMISPHERE TECHNOLOGIES, INC.
Reel/Frame 021683/0927 →